Money for regenerative medicine
This is simple. You can give real money to regenerative medicine without it costing you a dime. JPMorgan Chase & Co's Chase Community Giving program is giving away $5 million to the charities Continue Reading
The changing face of PR and why it matters to regenmed
This may seem a little off-topic for those who don't know me but for those of you who do, you'll know this is a little mix of many of my primary loves - cell therapy/regenerative medicine, Continue Reading
Biotech tax credit appears perfectly designed for cell therapy companies to recoup research dollars spent in 2009-10
Stewart Lyman of Lyman BioPharma Consulting posted a great article in today's Xconomy summarizing some key points and links to more information about the rules governing the Therapeutic Discovery Continue Reading
Google to Invest in Regenerative Medicine
While the US government prints money to shore up failing and broken business models which no one likes but are considered simply too big (not too important or significant or even useful) to fail, Continue Reading
Latest Cell Therapy Approval by FDA. Dendreon’s Provenge.
It has been a long-time coming. It has been hyped and scoffed, bet against and hoped for, but now none of that matters. It's here. Dendreon has brought Provenge to market. Here, in the word's of Continue Reading
Stem cells for a Webby!
I know I haven't been a very good blogger for quite some time but I wanted to pass on a letter I just received from my friend James Price as a Charter member of the Canadian Stem Cell Foundation. Continue Reading
Errata Statement re: Regenexx
It has been pointed out to me by legal counsel that the 25 July 2008 letter from the FDA to Regenerative Sciences, Inc regarding what FDA observed as apparent "violations" of FDA regulation by Continue Reading
The true status of the cell therapy industry…
I apologize for the quality of this image but hopefully its just clear enough for you to make out this week's Genetic Engineering News poll. If you're reading this in realtime you will see on GEN's Continue Reading
Cell Therapy Industry HiLites 2009-07-03
Last week I mentioned the Regenerative Medicine Foundation and the conference they have announced for Spring 2010. I promised to find out more and bring you what I learned.I've discovered that the Continue Reading
SBIR Funding – Should it be open to VCs?
I don't have much time to give you an extensive blog about the issue but I did want to bring this to your attention. Here's the nutshell.The NIH's SBIR (Small Business Innovation Research Program) Continue Reading
Cell Therapy Industry HiLites 2009-07-17
As Late, Late Show host, Craig Ferguson, says..."It's a great day for America. 'Why is it a great day for America,' you ask? Well, let me tell you".The US House of Representatives has passed what Continue Reading
Cell Therapy Industry HiLites 2009-06-12
“Autologous manufacturing is not the deal breaker it used to be. If these vaccines work for really difficult-to-treat diseases, the manufacturing issues will be worked out.” Howard Liang, Continue Reading
A Therapeutic Long Tail. Does Cell Therapy Fit the Model? (Part I)
I'm always skeptical of companies or products or technologies that depend on a 'paradigm-shift' or 'sea-change' in the long-entrenched habits of people before they will be widely adopted and/or Continue Reading
A Therapeutic Long Tail. Does Cell Therapy Fit the Model? (Part II)
...this is a continuation of Part I...So are Personalized Medicines the Long Tail of the Therapeutics Industry?In 2006, Chris Anderson, Editor-in-Chief of Wired magazine, released "The Long Tail" – Continue Reading
Cell Therapy Industry HiLites 2009-06-26
Let's get the public services announcement out of the way right up front.CellTherapy 2010. Save the date. Submit your session ideas. www.celltherapy2010.comWhile you're planning your calendar, plan Continue Reading
Cell Therapy Industry HiLites 2009-05-26
This week I'm ROTFLMAO loving this cartoon so I thought I'd share the chuckles (thanks to www.onstartups.com). I can't tell you how many times in the past years I've seen the inevitable 'hockey Continue Reading
Cell Therapy Industry HiLites 2009-05-15
I'm back.That on the left my friends is the new squawking reason I've been quite on the blogosphere and Twitter scene for the past few weeks!I know this issue of my Industry HiLites has some rather Continue Reading
ISCT 2009 Corporate Tutorials and Symposia
Here is a listing of the corporate tutorial and symposia sessions being held at the International Society for Cellular Therapy conference Sunday-Wednesday in San Diego. For more information see Continue Reading
Final Results of Dendreon’s phase III IMPACT Trial of Provenge
Dendreon Corporation (Nasdaq: DNDN) will host a conference call tomorrow, Tuesday, April 14, 2009, at 9:00 AM ET (6:00 AM PT) to review the outcome of the FINAL analysis of its IMPACT (IMmunotherapy Continue Reading
Cell Therapy Industry HiLites 2009-04-10
Here we are in April 2009. The much newly anticipated date when we expect the Dendreon saga to head toward a climax. Few people know the Dendreon story better then Xconomy journalist, Luke Timmerman Continue Reading
